Ceftizoxime
Chemical compound
From Wikipedia, the free encyclopedia
Ceftizoxime is a third-generation cephalosporin available for parenteral administration.[1] Unlike other third-generation cephalosporins, the whole C-3 side chain in ceftizoxime has been removed to prevent deactivation by hydrolytic enzymes. It rather resembles cefotaxime in its properties, but is not subject to metabolism. It was removed from the US Market in 2007.
 | |
| Clinical data | |
|---|---|
| Trade names | Cefizox |
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a684043 |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.210.846 |
| Chemical and physical data | |
| Formula | C13H13N5O5S2 |
| Molar mass | 383.40 g·mol−1 |
Synthesis
Injectable third generation cephalosporin antibiotic related to cefotaxime, q.v. Exhibits broad spectrum activity and resistance to β-lactamase hydrolysis.
